EcoDrugPlus

Ensembl ID : ENSPNAG00000019732
Gene Symbol: -
Cross references: -
350 Possible Orthologues:

Ensembl ID : ENSPNAG00000019771
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSPNAG00000025934
Gene Symbol: -
Cross references: -
188 Possible Orthologues:

Ensembl ID : ENSPNAG00000022964
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSPNAG00000014080
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSPNAG00000003782
Gene Symbol: -
Cross references: -
161 Possible Orthologues:

Ensembl ID : ENSPNAG00000007707
Gene Symbol: -
Cross references: -
228 Possible Orthologues:

Ensembl ID : ENSPNAG00000024140
Gene Symbol: -
Cross references: -
182 Possible Orthologues:

Ensembl ID : ENSPNAG00000024556
Gene Symbol: -
1 Cross references
233 Possible Orthologues:

Ensembl ID : ENSPNAG00000024526
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Ensembl ID : ENSPNAG00000021095
Gene Symbol: -
Cross references: -
215 Possible Orthologues:

Ensembl ID : ENSPNAG00000011719
Gene Symbol: -
Cross references: -
8 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).